ANAPTYSBIO Stock Price, News & Analysis
Company Description
ANAPTYSBIO (ANABV) is a publicly traded company.
ANABV stock has declined 3.8% over the past year.
On a trailing twelve-month basis, ANAPTYSBIO reported revenue of $234.6M with net income of -$13.2M and diluted earnings per share of $-0.46. The company operates at a net profit margin of -5.6%.
This page provides a comprehensive overview of ANABV stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
ANAPTYSBIO (ANABV) stock. Over the past 12 months, the stock has lost 3.8%.
ANABV Rankings
Latest News
SEC Filings
ANAPTYSBIO has filed 2 recent SEC filings, including 2 Form 8-K. The most recent filing was submitted on April 20, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all ANABV SEC filings →
Financial Highlights
ANAPTYSBIO generated $234.6M in revenue over the trailing twelve months, operating income reached $47.9M (20.4% operating margin), and net income was -$13.2M, reflecting a -5.6% net profit margin. Diluted earnings per share stood at $-0.46. The company generated $19.7M in operating cash flow. With a current ratio of 9.07, the balance sheet reflects a strong liquidity position.